Thanks to our extensive expertise and capacity, we have developed an offer to help IVD actors to comply with the new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) requirements by developing an efficient and robust alternative to disease-state plasma for your IVD standards.
Bcell Design’s platform is based on patented genetically modified mouse models secreting human chimeric antibodies.
Through this platform, IVD developers and manufacturers gain access to a wide range of monoclonal antibodies that are immediately ready for testing in human models.
Our IVD mAb standards (IgG, IgM and IgA) are used for positive controls, calibrators and quality controls.
High-quality products: sensitivity, specificity, selectivity
Perfect batch-to-batch reproducibility
Ready to use